28th May 2015 09:31
LONDON (Alliance News) - Life sciences company OptiBiotix Health PLC on Thursday said it has filed three new patent applications.
The new patents related to the company's OptiBiotic platform technology, which generates novel oligosaccharides, or carbohydrates that consists of a small number of sugars.
"We are pleased to announce the filing of these patents which protect the recent advances we have made in developing novel sugars with the potential to act as calorie free sweeteners and modulate the human microbiome to prevent, manage, and treat disease," said Chief Executive Stephen O'Hara.
Shares in OptiBiotix were up 2.0% to 40.40 pence on Thursday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
OptiBiotix Health